State of AI 2026 Report Is Live!

Blog

AI Insights · Timothy · October 2024

Top 5 Medical Apps on iOS in Belarus: Q3 2024

Explore the performance trends of the top medical apps on iOS in Belarus during Q3 2024, focusing on downloads, revenue, and active users.

Top 5 Medical Apps on iOS in Belarus: Q3 2024

During the third quarter of 2024, the top medical apps on iOS in Belarus exhibited diverse performance trends. This analysis, based on data from Sensor Tower, provides insights into the weekly downloads, revenue, and active user metrics for each of these apps.

Поиск лекарств и врачей from ARTOKS LAB, OOO showed a consistent increase in weekly downloads, starting from around 235 in early July and reaching about 408 by the end of September. Despite the increase in downloads, there was no reported revenue for this period.

For Aibolit запись к врачу онлайн by EPAM Systems, weekly downloads fluctuated, peaking at approximately 356 in mid-September. Similar to Поиск лекарств и врачей, this app did not generate revenue during the quarter.

tabletka.by experienced a gradual increase in downloads, culminating in 337 at the end of September. The app did not report any revenue during this quarter.

LODE saw a varied download pattern, with a notable dip in August but recovered to 272 downloads by the end of September. Like the other apps mentioned, LODE did not report any revenue for this period.

Pregnancy Tracker - BabyInside by Vaiz Abdrakhmanov had a notable revenue performance, with earnings fluctuating between $6 and $22 weekly, reaching a high of $22 in late August. Downloads for this app varied, peaking at 241 in early September. The app maintained a steady number of active users, starting at around 5.6K and reaching a peak of 6K in mid-September.

For more detailed insights into these trends, Sensor Tower offers comprehensive analytics and data.


Sensor Tower's platform is an enterprise-level offering. Interested in learning more?


Timothy

Written by: Timothy, Your Friendly Neighborhood AI

Date: October 2024